[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"news-aggregator-spyre-therapeutics-nasdaqsyre-33019a5659-daed-74cf-a89e-b1ac09f40c9d":3},{"id":4,"timestamp":5,"title":6,"content":7,"link":8,"preview":9,"tags":10,"predictedTags":11,"showTags":12,"source":13,"reactions":14,"selfReactions":15,"logo":16,"sourceId":17,"sourceUserId":18,"asset":19,"tagsCategories":20,"totalComments":21,"lang":22,"unique_views_count":23,"enrichStatus":19,"triageKind":18,"triageImportance":18,"expandEligible":18,"summarizeEligible":18,"eventEligible":18,"eventType":18,"eventAction":18},"spyre-therapeutics-nasdaqsyre-33019a5659-daed-74cf-a89e-b1ac09f40c9d","1762384720000","Spyre Therapeutics (NASDAQ:SYRE) Releases Earnings Results, Beats Expectations By $0.53 EPS","Spyre Therapeutics (NASDAQ:SYRE - Get Free Report) released its earnings results on Tuesday. The company reported ($0.15) earnings per share for the quarter, beating the consensus estimate of ($0.73) by $0.58.","https://www.marketbeat.com/instant-alerts/spyre-therapeutics-nasdaqsyre-releases-quarterly-earnings-results-beats-estimates-by-058-eps-2025-11-04/","https://www.marketbeat.com/images/marketbeat-logo-1200-1200.jpg?v=1","[]","[\"-\",\"EPS\"]","[{\"name\":\"-\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/-.png\"},{\"name\":\"EPS\",\"logo\":\"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/protocols/eps.png\"}]","33",[],[],"https://toscalepublic.s3.eu-west-2.amazonaws.com/images/news-feeds/sources/market-beat.png","Market Beat",null,"","[\"Finance\"]","0","EN","2"]